Will OpenAI or Anthropic IPO first?

**Stage 1 — Blind analysis (ignore current market price):**

I evaluate the question purely on public signals, incentives, business models, and plausible structural constraints. On balance, the evidence—public commentary from OpenAI leadership about IPO timing, leaked chatter about an accelerated timeline, and OpenAI's product/revenue rollout—points to OpenAI being the more likely to reach a public offering before Anthropic. Important, though, is that Anthropic is a serious competitor with substantial backers and a product roadmap that could accelerate its own path to public markets if it chooses.

Key factual and structural inputs informing my independent probability:

- *Corporate signaling and public discussion.* OpenAI executives (including the CFO) have discussed IPO timing publicly, which is a concrete signal of active planning. Anthropic has not shown comparable public signaling in the provided context. - *Revenue and market position.* As of the available information, OpenAI has broader consumer and enterprise product penetration (platforms, API monetization, embedded partnerships), which creates clearer revenue narratives an IPO prospectus can use. That reduces the structural friction to a listing relative to a purely research-driven story. - *Strategic investor posture.* Large strategic investors (notably Microsoft) create ambiguous incentives: they can either accelerate an IPO (to crystallize value and create a public market float) or prefer to keep the company private to maintain preferential access. The balance here favors an IPO if OpenAI wants to broaden investor base and governance transparency. - *Complex governance and technical/regulatory risks.* OpenAI's unusual LP / non-profit-linked structure and the national-security/competition scrutiny around advanced AI introduce real complexity that could delay or reshape any IPO plan. - *Time horizon (through 2040).* Given the long horizon, path dependency favors the firm with earlier preparatory signals and larger near-term monetization opportunities. Over 14+ years, the chance that at least one firm lists first becomes near-certain; the question is which will do so first.

I weigh these inputs and conclude that OpenAI has a clear lead in likelihood to IPO before Anthropic. However, there are meaningful countervailing uncertainties (acquisition risk, governance complications, strategic investor preferences, or deliberate long-term private strategy) that prevent treating this as near-certain.

Quantitatively, combining qualitative priors (signal asymmetry), strategic incentives, and long-horizon dynamics, I place the independent probability at **72%** that OpenAI will IPO before Anthropic by 2040.

**Stage 2 — Market calibration (compare to current market prices):**

The market price you supplied is Yes = 0.78. My independent probability (0.72) is moderately lower than the market. Possible reasons the market is pricing OpenAI-first higher than I do:

- *Recency and signal overweighting.* Markets often overweight recent leaks and public comments (CFO podcast, May 2026 leak) and translate them into higher near-term probabilities even though those signals may only indicate active evaluation rather than an imminent filing. - *Retail / narrative momentum.* OpenAI has outsized brand recognition and retail interest; traders may crowd into a simple bullish narrative (OpenAI will go public first) more aggressively than fundamentals warrant. - *Information asymmetry / insider belief.* Professional traders who price these markets may have access to incremental rumor flow or read signals (e.g., banking outreach, draft S-1 work) more optimistically than my public-source-limited view; that would justify a higher price. - *Low perceived downside.* Participants might assume the path to IPO is straightforward once signalling begins; that assumption pushes the price up versus a more cautious view that discounts governance and regulatory friction.

Why I remain somewhat more conservative than the market:

- *Governance complexity and strategic investor incentives* are real and can delay or prevent an IPO even when leadership discusses timing. Those are underappreciated in short-term narratives. - *Acquisition / alternative outcomes.* A large strategic investor could buy a controlling stake or reach arrangements that make a public listing unnecessary or unattractive. Markets sometimes underweight M&A-as-alternative-to-IPO risk.

Net calibration conclusion: the market is plausibly but not overwhelmingly optimistic; my 72% view reflects a modest discount to the market price for governance/regulatory and M&A tail risks that are easy to under-appreciate by traders focused on signalling. If I believed the market had access to hard preparatory evidence (bankers mandated, draft S-1), I would move closer to 78% — absent that, 72% is my independent estimate.